{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:35:51Z","timestamp":1786718151184,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/51\/I\/NZ3\/02005"],"award-info":[{"award-number":["2023\/51\/I\/NZ3\/02005"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Epitope spreading has long been proposed as a mechanism contributing to the progression of multiple sclerosis (MS), yet its role in human disease remains incompletely defined. Traditionally viewed as a consequence of antigen release during tissue damage, epitope spreading is often considered independently of the anatomical context in which immune responses occur. Here, I re-examine epitope spreading in MS by integrating evidence from experimental models and human studies with recent advances in neuroimmunology. I propose that the diversification of autoreactive responses is not solely driven by antigen availability but is shaped by the spatial organisation of immune cells within the central nervous system (CNS), CNS-draining lymph nodes, and peripheral lymphoid tissues. In particular, I highlight EBI2 (GPR183) as a candidate regulator of immune-cell positioning that may influence the cellular interactions required for the emergence of new antigen specificities. This spatial framework links epitope spreading with germinal-centre dynamics, B-cell-mediated immunity, and Epstein\u2013Barr virus-associated mechanisms in MS, while emphasising that direct evidence connecting EBI2 to epitope spreading remains limited. Defining how autoreactive diversification is controlled may help explain disease progression and guide strategies aimed at limiting the evolution of pathogenic immune responses.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1878029","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:45Z","timestamp":1785212745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epitope spreading in multiple sclerosis is shaped by the spatial organisation of immune responses"],"prefix":"10.3389","volume":"17","author":[{"given":"Aleksandra","family":"Rutkowska","sequence":"first","affiliation":[{"name":"Department of Anatomy and Neurobiology, Rutkowska Lab, Medical University of Gda\u0144sk","place":["Gdansk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/V13020277","article-title":"Viral infections and systemic lupus erythematosus: New players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/358155A0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90163-F","article-title":"Determinant spreading and the dynamics of the autoimmune T-cell repertoire","volume":"14","author":"Lehmann","year":"1993","journal-title":"Immunol Today"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.2.670","article-title":"Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis 1","volume":"164","author":"Vanderlugt","year":"2000","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(02)00080-0","article-title":"Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler\u2019s virus-induced demyelinating disease model of multiple sclerosis","volume":"1","author":"Croxford","year":"2002","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/S-0040-1715641","article-title":"From Anti-EBV Immune Responses to the EBV Diseasome via Cross-Reactivity","volume":"7","author":"Kanduc","year":"2020","journal-title":"Glob Med Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/JAUT.1999.0293","article-title":"Regression and spreading of self-recognition during the development of autoimmune demyelinating disease","volume":"13","author":"Tuohy","year":"1999","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/64.5.371","article-title":"Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis","volume":"64","author":"Davies","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.3.508","article-title":"Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence","author":"Goebels","year":"2000","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001066","article-title":"Epitope spreading as an early pathogenic event in pediatric multiple sclerosis","volume":"83","author":"Quintana","year":"2014","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/glia.22309","article-title":"The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis","volume":"60","author":"Batoulis","year":"2012","journal-title":"Glia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.186.12.2039","article-title":"Determinant spreading of \u2009T helper cell 2 (Th2) responses to pancreatic islet autoantigens","volume":"186","author":"Tian","year":"1997","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.8241","article-title":"Coadministration of plasmid DNA constructs encoding an encephalitogenic determinant and IL-10 elicits regulatory T cell-mediated protective immunity in the central nervous system","volume":"177","author":"Schif-Zuck","year":"2006","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: Implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm1202","article-title":"Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis","volume":"11","author":"McMahon","year":"2005","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2003.08.032","article-title":"Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler\u2019s virus model of multiple sclerosis","volume":"144","author":"Mack","year":"2003","journal-title":"J Neuroimmunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/path.2476","article-title":"Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis","volume":"217","author":"van Zwam","year":"2009","journal-title":"J Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt859","article-title":"Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis","volume":"21","author":"Robinson","year":"2003","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.1690","article-title":"Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis","volume":"170","author":"Jones","year":"2003","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2513","article-title":"MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells","volume":"14","author":"Ji","year":"2013","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90063-2","article-title":"Blockade of CD28\/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE","volume":"3","author":"Miller","year":"1995","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5388","article-title":"Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis","volume":"103","author":"Howard","year":"1999","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008523117","article-title":"A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis","volume":"117","author":"Ramesh","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/CTI2.1457","article-title":"Epstein\u2013Barr virus and multiple sclerosis: The dawn of a new age","volume":"12","author":"Phan","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.3390\/IJMS24087407","article-title":"Epstein-Barr virus and multiple sclerosis: A convoluted interaction and the opportunity to unravel predictive biomarkers","volume":"24","author":"Ortega-Hernandez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00777","article-title":"Exposure to the Epstein-Barr viral antigen latent membrane protein 1 induces myelin-reactive antibodies in vivo","volume":"8","author":"Lomakin","year":"2017","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/CTI2.1438","article-title":"Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials","volume":"12","author":"Lanz","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/S12276-025-01482-5","article-title":"Epstein-Barr virus and multiple sclerosis: Lesson learned to develop better nonhuman primate models","volume":"57","author":"Nguyen","year":"2025","journal-title":"Exp Mol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-5728(00)00384-2","article-title":"Modulation of the IL-10\/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis","volume":"111","author":"Tuohy","year":"2000","journal-title":"J Neuroimmunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.01.020","article-title":"EBI2 is highly expressed in multiple sclerosis lesions and promotes early CNS migration of encephalitogenic CD4 T cells","volume":"18","author":"Wanke","year":"2017","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3390\/ijms22094342","article-title":"Ebi2 is temporarily upregulated in mo3.13 oligodendrocytes during maturation and regulates remyelination in the organotypic cerebellar slice model","volume":"22","author":"Velasco-Estevez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2014.10.001","article-title":"Oxysterols regulate encephalitogenic CD4+ T cell trafficking during central nervous system autoimmunity","volume":"56","author":"Chalmin","year":"2015","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-017-1025-0","article-title":"EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination","volume":"14","author":"Rutkowska","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15359","article-title":"EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model","volume":"54","author":"Klejbor","year":"2021","journal-title":"Eur J Neurosci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117653","article-title":"Accelerated remyelination and immune modulation by the EBI2 agonist 7\u03b1,25-dihydroxycholesterol analogue in the cuprizone model","volume":"181","author":"Konieczna-Wolska","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2VMR1217-510R","article-title":"EBI2 in splenic and local immune responses and in autoimmunity","volume":"104","author":"Barington","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature08226","article-title":"EBI2 mediates B cell segregation between the outer and centre follicle","volume":"460","author":"Pereira","year":"2009","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.06.015","article-title":"Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses","volume":"37","author":"Yi","year":"2012","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2555","article-title":"The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells","volume":"14","author":"Gatto","year":"2013","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00757","article-title":"EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture","volume":"2","author":"Yi","year":"2013","journal-title":"Elife"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04136-4","article-title":"Antigen-presenting innate lymphoid cells orchestrate neuroinflammation","volume":"600","author":"Grigg","year":"2021","journal-title":"Nat"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02431-z","article-title":"Recruitment of \u03b14\u03b27 monocytes and neutrophils to the brain in experimental colitis is associated with elevated cytokines and anxiety-like behavior","volume":"19","author":"Cluny","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-019-1541-1","article-title":"Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA","volume":"16","author":"Derdelinckx","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.12.002","article-title":"Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities","volume":"27","author":"Smith","year":"2006","journal-title":"J Autoimmun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027860","article-title":"Multi-epitope-targeted\u201d immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides","volume":"6","author":"Kaushansky","year":"2011","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1038\/s41598-021-84751-3","article-title":"Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis","volume":"11","author":"Tian","year":"2021","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12525","article-title":"Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading","volume":"171","author":"Cavone","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20190097","article-title":"Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients","volume":"77","author":"Comini-Frota","year":"2019","journal-title":"Arq Neuropsiquiatr"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1953873","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1878029\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:30:47Z","timestamp":1786714247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1878029\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2026.1878029"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1878029","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1878029"}}